Vanguard Capital Management’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
Vanguard Capital Management's ORKA Position: Q3 2026 in Review
Vanguard Capital Management increased its Oruka Therapeutics (ORKA) stake by 12% in Q3 2026, buying an estimated $26.7M and bringing the position to 2,644,280 shares worth $220M. The position accounts for ﹤0.01% of the portfolio, ranked #1043.
Vanguard Capital Management first reported a position in ORKA in Q1 2026 and has held it in 3 quarters since. The position peaked at $225M in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- Vanguard Capital Management held 2,644,280 shares of Oruka Therapeutics worth $220M as of Q3 2026.
- Vanguard Capital Management bought 283,309 Oruka Therapeutics shares in Q3 2026, an estimated $26.7M.
- Oruka Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1043 holding.
- Vanguard Capital Management first reported a position in Oruka Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Oruka Therapeutics position peaked at $225M in Q2 2026.
- 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.